Publication: Pediatric Kidney Transplantation in Thailand: Experience in a Developing Country
1
Issued Date
2008-09-01
Resource Type
ISSN
00411345
Other identifier(s)
2-s2.0-51249124881
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Transplantation Proceedings. Vol.40, No.7 (2008), 2271-2273
Suggested Citation
A. Sumboonnanonda, A. Lumpaopong, P. Kingwatanakul, K. Tangnararatchakit, A. Jiravuttipong Pediatric Kidney Transplantation in Thailand: Experience in a Developing Country. Transplantation Proceedings. Vol.40, No.7 (2008), 2271-2273. doi:10.1016/j.transproceed.2008.07.023 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/19569
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Pediatric Kidney Transplantation in Thailand: Experience in a Developing Country
Abstract
From July 1996 to November 2006, 46 patients received kidney transplants at five pediatric centers in Thailand. The male-female ratio was 1.9:1. The primary causes of end-stage renal disease (ESRD) included hypoplastic or dysplastic kidney, chronic glomerulonephritis, reflux nephropathy, pyelo nephritis or interstitial nephritis, focal segmental glomerulosclerosis, and rapidly progressive glomerulonephritis. Mean (SD) age at onset of ESRD was 10.1 (3.1) years, and at transplantation was 11.1 (2.9) years. Preemptive transplantation was performed in 2 patients. Cadaveric donors were used in 67.4% of procedures. Induction of immunosuppression with interleukin (IL)-2 monoclonal antibody was used in 41.3% of the patients. At 1 year posttransplantation, maintenance therapy included corticosteroids in 100% of patients, cyclosporine in 81.6%, tacrolimus in 15.8%, azathioprine in 31.6%, and mycophenolate mofetil in 57.9%. Standardized height z scores at transplantation and last follow-up (mean [SD], 40.0 [28.3] months) remained the same at -1.9. Mean (SD) serum creatinine level at the last follow-up was 1.3 (0.8) mg/dL. Patient survival at 1 and 5 years was 96% and 88%, respectively. Graft survival at 1 and 5 years was 98% and 84%, respectively. The medical expenses at 1, 6, and 12 months were US$601, US$464, and US$384 per month, respectively. The Thai per gross domestic product per capita was US$758 per month. Medical expenses were paid by the government in 44.2% of cases, charity foundations in 39.5%, and the patients' parents in 16.3%. Although the causes, management, and outcomes of ESRD were not different from those in other countries, access to treatment and medical expenses may be substantial barriers in developing countries. © 2008 Elsevier Inc. All rights reserved.